eHealthMe - FDA and Social Media, Personalized eHealthMe - a cloud computing service for drugs

FDA and Social Media, Personalized

Advanced tools

Review: could Elmiron cause Infusion related reaction?

We study 1,868 people who have side effects while taking Elmiron from FDA and social media. Among them, 7 have Infusion related reaction. Find out below who they are, when they have Infusion related reaction and more.

Stay connected: join a mobile support group for people who take Elmiron and have Infusion related reaction >>>

Elmiron

Elmiron (latest outcomes from 1,985 users) has active ingredients of pentosan polysulfate sodium. It is often used in interstitial cystitis (ic).

Infusion related reaction

Infusion related reaction (latest reports from 55,783 patients) has been reported by people with crohn's disease, rheumatoid arthritis, premedication, multiple sclerosis, ulcerative colitis.

On Aug, 28, 2014: 1,868 people reported to have side effects when taking Elmiron. Among them, 7 people (0.37%) have Infusion Related Reaction. They amount to 0.01% of all the 55,783 people who have Infusion Related Reaction on eHealthMe.

Trend of Infusion related reaction in Elmiron reports

Time on Elmiron when people have Infusion related reaction * :

n/a

Gender of people who have Infusion related reaction when taking Elmiron * :

FemaleMale
Infusion related reaction100.00%0.00%

Age of people who have Infusion related reaction when taking Elmiron * :

0-12-910-1920-2930-3940-4950-5960+
Infusion related reaction0.00%0.00%0.00%0.00%16.67%83.33%0.00%0.00%

Severity of Infusion related reaction when taking Elmiron ** :

n/a

How people recovered from Infusion related reaction ** :

n/a

Top conditions involved for these people * :

  1. Crohn's disease (5 people, 71.43%)
  2. Rheumatoid arthritis (4 people, 57.14%)
  3. Colitis ulcerative (4 people, 57.14%)
  4. Hormone replacement therapy (4 people, 57.14%)
  5. Cystitis interstitial (4 people, 57.14%)

Top co-used drugs for these people * :

  1. Remicade (5 people, 71.43%)
  2. Lexapro (4 people, 57.14%)
  3. Asacol (4 people, 57.14%)
  4. Estrogenic substance (4 people, 57.14%)
  5. Unspecified crohn's disease therapy (4 people, 57.14%)

* Approximation only. Some reports may have incomplete information.

** Reports from social media are used.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

You can also:

Get connected! Join a mobile support group:
- group for people who take Elmiron and have Infusion Related Reaction
- group for people who take Elmiron
- group for people who have Infusion Related Reaction

Comments from related studies:

  • From this study (5 months ago):

  • Stools problem is ok.. but I'm scared about hair lose

    Reply

  • From this study (1 year ago):

  • I was given this drug for pain in lower left pelvic area, after 3 doses, I lost control of my ability to control urination and urine just flows out

    Reply

Post a new comment    OR    Read more comments

Can you answer these questions (what is this?):

More questions for: Elmiron, Infusion related reaction

More reviews for: Elmiron, Infusion related reaction

On eHealthMe, Elmiron (pentosan polysulfate sodium) is often used for interstitial cystitis (ic). Find out below the conditions Elmiron is used for, how effective it is, and any alternative drugs that you can use to treat those same conditions.

What is Elmiron used for and how effective is it:

Other drugs that are used to treat the same conditions:

Could it be a symptom from a condition:

Drugs in real world that are associated with:

Could your condition cause it?

NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

40 million health professionals and patients have studied on eHealthMe. Recent studies:

- Allegra-d 12 Hour, Amoxicillin And Clavulanate Potass ... (39 seconds ago)

- Clomid for a 54-year old man who has Not Sure (21 minutes ago)

- Vyvanse for a 14-year old girl who has ADHD (41 minutes ago)

Related study

- Elmiron side effects

 

Related symptom

- Infusion Related Reaction

 

 

Recent user comments

- "Leg muscle weakness and cramps with consequent knee p ... " (3 hours ago)

- "I have recently been diagnosed with an underactive Th ... " (4 hours ago)

- "i have a hot face on a daily basis, and i get hot flu ... " (9 hours ago)

 

Recent mobile support groups

- Erectile Dysfunction and Flonase

- Polymyalgia

- Polymyalgia Rheumatica

- Butrans

- Marijuana and Lack Of Strength, Muscle Weakness, Weakness

 

Popular searches

- Lorbeerweide
- Uceris
- Joint Pain
- Type 2 Diabetes
- Prednisone

   

All drugs: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
All conditions: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

About - Terms of service - Privacy policy - Press - Advertise - Apps - Testimonials - Contact us

 
© 2014 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.